News – Page 133 – Endpoints News

Novo Nordisk takes $816M writedown after Phase 3 fail in chronic kidney disease

10 months ago

FDA publishes long-awaited guidance on clinical trial diversity

10 months ago

Taysha’s $75M offering; Augustine raises €17M

10 months ago

Moderna's updated RSV vaccine disappoints with only 50% efficacy

10 months ago

With a $372M megaround, Formation Bio looks to in-license 10+ drugs

10 months ago

Alexis Borisy and Zach Weinberg's Curie.Bio secures $380M to support portfolio's Series A rounds

10 months ago

Zealand rides obesity wave with $1B raise to advance amylin drug and look for a partner

10 months ago

Lyell reports patient death, early responses in solid tumor CAR-T trial

10 months ago

Arrowhead shelves one cardiometabolic drug candidate, focuses on another

10 months ago

Lilly becomes the latest pharma to tap OpenAI for help, this time for antibiotic work

10 months ago

Can CRISPR be given twice? Small study from Intellia suggests it can

10 months ago

Q&A: FDA medical policy chief talks decentralized trial guidance, improving diversity

10 months ago

Amgen calls Colorado's price controls on Enbrel 'unconstitutional'

10 months ago

Teva to pay $750M to resolve Israel tax disputes

10 months ago

Wave Life Sciences touts Huntington's disease win in Phase 1b/2a trial

10 months ago

Zealand Pharma aims to raise $900M; Boehringer discontinues three Phase 2 trials

10 months ago

Ginkgo to cut at least 35% of staff in multi-year restructuring plan

10 months ago

Biopharma leaders charting a path for the industry's LGBTQ+ community

10 months ago

Exclusive: Cityblock Health investors buy employee shares in tender offer

10 months ago

FDA again rejects AbbVie's continuous infusion therapy for Parkinson's

10 months ago

J&J's Tremfya fails giant cell arteritis study, where Roche and AbbVie have succeeded

10 months ago

AstraZeneca’s Imfinzi aces Phase 3 test in bladder cancer, fails another in lung cancer

10 months ago

New cancer biotech emerges from Stanford research, with help of Nobel laureate Carolyn Bertozzi

10 months ago

Ex-Meta scientists launch EvolutionaryScale with $142M seed round, unveiling next-gen AI model for protein design

10 months ago

First page Previous page 130 131 132133134 135 136 Next page Last page